The remdesivir group also showed a trend towards a reduction in mortality (11.4% vs. 15.2%) and less frequent use of mechanical ventilation or ECMO (13% vs. 23%) [ 81 ].
← all excerpts
COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.
1
—
—